Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 1529
Journal of Infectious Diseases & Therapy received 1529 citations as per Google Scholar report
Indexed In
- Index Copernicus
- Google Scholar
- Open J Gate
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Effectiveness of convalescent plasma therapy in COVID-19 patients
Joint Event : 10th International Congress on Infectious Diseases & 12th International Conference on Tropical Medicine and Infectious Diseases
Ghazala Rubi
Lahore General Hospital, Pakistan
ScientificTracks Abstracts: J Infect Dis Ther
Abstract
Background: COVID-19 is an infectious disease caused by a newly identified strain of coronavirus (SARSCoV- 2). This strain is responsible for respiratory infections in humans. Objective: The objective of this study was to analyze the clinical efficacy and safety of Convalescent Plasma (CP) therapy in Corona Virus Disease 2019 (COVID-19) cases. Design: This was an experimental trial of COVID-19 patients treated with Convalescent Plasma (CP) therapy; these patients were admitted in Lahore General Hospital, Lahore, Pakistan during April 24 to august 24, 2021. Findings: Pearson correlation was applied to extract the efficacy of Convalescent Plasma therapy (CP). A p-value ΓΆΒ?Β¤ 0.05 was considered significant. 16 out of 20 patients (80%) were completely recovered from COVID-19. Conclusions: Convalescent Plasma (CP) proved to be an effective and safe therapy for confirmed cases of COVID-19. However, two critically ill patients died. Keywords: COVID-19, Convalescent Plasma (CP) therapy, Symptoms, Critically ill.Biography
Ghazala Rubi is the Director of Research Laboratory. She completed her Post Graduation in Medical Institute & Lahore General Hospital, Lahore, Pakistan.
